Nitric oxide prevents aortic valve calcification by S-nitrosylation of USP9X to activate NOTCH signaling

Citations Over TimeTop 10% of 2021 papers

Abstract

Calcific aortic valve disease (CAVD) is an increasingly prevalent condition, and endothelial dysfunction is implicated in its etiology. We previously identified nitric oxide (NO) as a calcification inhibitor by its activation of NOTCH1, which is genetically linked to human CAVD. Here, we show NO rescues calcification by an S-nitrosylation-mediated mechanism in porcine aortic valve interstitial cells and single-cell RNA-seq demonstrated NO regulates the NOTCH pathway. An unbiased proteomic approach to identify S-nitrosylated proteins in valve cells found enrichment of the ubiquitin-proteasome pathway and implicated S-nitrosylation of USP9X (ubiquitin specific peptidase 9, X-linked) in NOTCH regulation during calcification. Furthermore, S-nitrosylated USP9X was shown to deubiquitinate and stabilize MIB1 for NOTCH1 activation. Consistent with this, genetic deletion of Usp9x in mice demonstrated CAVD and human calcified aortic valves displayed reduced S-nitrosylation of USP9X. These results demonstrate a previously unidentified mechanism by which S-nitrosylation-dependent regulation of a ubiquitin-associated pathway prevents CAVD.

Related Papers

• → New Insights into Protein S-Nitrosylation(2004)176 cited
• → Oxidative stress and S‐nitrosylation of proteins in cells(2000)194 cited
• → Calcification resistance with aluminum-ethanol treated porcine aortic valve bioprostheses in juvenile sheep(2003)30 cited
• Progress in Research Techniques of Protein S-nitrosylation and Its Role in Plant Disease Resistance(2010)
• Protein S-nitrosylation and neurodegenerative diseases(2012)